Ibrance (palbociclib) is an FDA approved hormone based treatment for metastatic breast cancer. This cancer drug treats patients who are post menopausal and whose advanced cancer tests positive for an estrogen receptor (ER) as well as tests negative for the HER2 protein. Oncologist Dr. Stephen Lemon talks about how Ibrance works, as well as covers some of the side effects it may cause. Please visit https://www.lightersideofcancer.com/education/ to learn more about other types of cancer treatments.
Ibrance is made by Pfizer. Dr. Lemon is a medical oncologist who is not affiliated with Pfizer.